These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Structure activity relationship and modeling studies of inhibitors of lysine specific demethylase 1. Zhou C; Wu F; Lu L; Wei L; Pai E; Yao Y; Song Y PLoS One; 2017; 12(2):e0170301. PubMed ID: 28158205 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Lysine-Specific Demethylase-1 (LSD1/KDM1A) Promotes the Adipogenic Differentiation of hESCs Through H3K4 Methylation. Xiong Y; Wang E; Huang Y; Guo X; Yu Y; Du Q; Ding X; Sun Y Stem Cell Rev Rep; 2016 Jun; 12(3):298-304. PubMed ID: 27059868 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures. Ota Y; Kakizawa T; Itoh Y; Suzuki T Molecules; 2018 May; 23(5):. PubMed ID: 29734782 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of γ-turn mimetics as LSD1-selective inhibitors. Ota Y; Miyamura S; Araki M; Itoh Y; Yasuda S; Masuda M; Taniguchi T; Sowa Y; Sakai T; Itami K; Yamaguchi J; Suzuki T Bioorg Med Chem; 2018 Feb; 26(3):775-785. PubMed ID: 29331452 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Yang M; Culhane JC; Szewczuk LM; Jalili P; Ball HL; Machius M; Cole PA; Yu H Biochemistry; 2007 Jul; 46(27):8058-65. PubMed ID: 17569509 [TBL] [Abstract][Full Text] [Related]
11. Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1. Dai XJ; Liu Y; Xue LP; Xiong XP; Zhou Y; Zheng YC; Liu HM J Med Chem; 2021 Mar; 64(5):2466-2488. PubMed ID: 33619958 [TBL] [Abstract][Full Text] [Related]
13. Catalytic mechanism investigation of lysine-specific demethylase 1 (LSD1): a computational study. Kong X; Ouyang S; Liang Z; Lu J; Chen L; Shen B; Li D; Zheng M; Li KK; Luo C; Jiang H PLoS One; 2011; 6(9):e25444. PubMed ID: 21984927 [TBL] [Abstract][Full Text] [Related]
15. Mining the Dynamical Properties of Substrate and FAD Binding Pockets of LSD1: Hints for New Inhibitor Design Direction. Yang K; Liu H J Chem Inf Model; 2024 Jun; 64(12):4773-4780. PubMed ID: 38837697 [TBL] [Abstract][Full Text] [Related]
16. LSD1 in drug discovery: From biological function to clinical application. Liu HM; Zhou Y; Chen HX; Wu JW; Ji SK; Shen L; Wang SP; Liu HM; Liu Y; Dai XJ; Zheng YC Med Res Rev; 2024 Mar; 44(2):833-866. PubMed ID: 38014919 [TBL] [Abstract][Full Text] [Related]
17. Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy. Chen Y; Jie W; Yan W; Zhou K; Xiao Y Crit Rev Eukaryot Gene Expr; 2012; 22(1):53-9. PubMed ID: 22339659 [TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking. Zhou C; Kang D; Xu Y; Zhang L; Zha X Chem Biol Drug Des; 2015 Jun; 85(6):659-71. PubMed ID: 25346381 [TBL] [Abstract][Full Text] [Related]
19. Development and Structural Evaluation of N-Alkylated trans-2-Phenylcyclopropylamine-Based LSD1 Inhibitors. Niwa H; Sato S; Handa N; Sengoku T; Umehara T; Yokoyama S ChemMedChem; 2020 May; 15(9):787-793. PubMed ID: 32166890 [TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Histone Lysine-Specific Demethylase 1 and Its Inhibitors. Zheng YC; Ma J; Wang Z; Li J; Jiang B; Zhou W; Shi X; Wang X; Zhao W; Liu HM Med Res Rev; 2015 Sep; 35(5):1032-71. PubMed ID: 25990136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]